Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-20

Clinical Trial Update: Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating single doses of SBT777101 in adults with rheumatoid arthritis. The trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SBT777101

Snippet

Sponsor: Sonoma Biotherapeutics, Inc. | Conditions: Rheumatoid Arthritis | Phase 1 | Status: RECRUITING